We are live on ! Find out more
TRCT

Tower Research Capital (TRC) Portfolio holdings

AUM $3.85B
1-Year Est. Return 32.11%
This Fund
S&P 500
This Quarter Est. Return
+26.23%
1 Year Est. Return
+32.11%
3 Year Est. Return
+93.86%
5 Year Est. Return
+112.79%
10 Year Est. Return
+380.9%
AUM
$2.44B
AUM Growth
+$792M
Cap. Flow
+$442M
Cap. Flow %
18.15%
Top 10 Hldgs %
14.39%
Holding
5,222
New
2,059
Increased
1,821
Reduced
839
Closed
374

Sector Composition

Rank Sector Weight
1 Technology 12.14%
2 Healthcare 9.57%
3 Financials 8.79%
4 Industrials 7.76%
5 Consumer Discretionary 7.68%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
KROS icon
3901
Keros Therapeutics
KROS
$212M
$13K ﹤0.01%
+347
New +$10.7K
KWEB icon
3902
KraneShares CSI China Internet ETF
KWEB
$5.76B
$13K ﹤0.01%
207
-1,093
-84% -$57.1K
NINE
3903
DELISTED
Nine Energy Service
NINE
$13K ﹤0.01%
6,473
-8,388
-56% -$14.1K
PSCC icon
3904
Invesco S&P SmallCap Consumer Staples ETF
PSCC
$40.9M
$13K ﹤0.01%
534
-150
-22% -$3.46K
QLC icon
3905
FlexShares US Quality Large Cap Index Fund
QLC
$1.05B
$13K ﹤0.01%
377
QMCO icon
3906
Quantum Corp
QMCO
$464M
$13K ﹤0.01%
171
-133
-44% -$10.5K
SLNO
3907
DELISTED
Soleno Therapeutics
SLNO
$13K ﹤0.01%
+401
New +$17.4K
UHAL icon
3908
U-Haul Holding Co
UHAL
$14.4B
$13K ﹤0.01%
440
-1,890
-81% -$55.4K
ZLAB icon
3909
Zai Lab
ZLAB
$2.65B
$13K ﹤0.01%
+163
New +$11K
SBT
3910
DELISTED
Sterling Bancorp, Inc. Common Stock
SBT
$13K ﹤0.01%
+3,515
New +$11.6K
TARO
3911
DELISTED
Taro Pharmaceutical Industries Ltd.
TARO
$13K ﹤0.01%
194
-46
-19% -$3.08K
IMBI
3912
DELISTED
iMedia Brands, Inc. Class A Common Stock
IMBI
$13K ﹤0.01%
+3,841
New +$9.98K
CHRA
3913
DELISTED
Charah Solutions, Inc Common Stock
CHRA
$13K ﹤0.01%
+414
New +$7.18K
DTP
3914
DELISTED
DTE Energy Company 2019 Corporate Units
DTP
$13K ﹤0.01%
300
-3,653
-92% -$151K
CHNGU
3915
DELISTED
Change Healthcare Inc. Tangible Equity Units
CHNGU
$13K ﹤0.01%
+300
New +$13.4K
LUB
3916
DELISTED
Luby's Inc.
LUB
$13K ﹤0.01%
9,049
+7,732
+587% +$7.71K
MJCO
3917
DELISTED
Majesco
MJCO
$13K ﹤0.01%
+1,616
New +$10.2K
AIRG icon
3918
Airgain
AIRG
$71.7M
$12K ﹤0.01%
+1,150
New +$9.81K
ATNM icon
3919
Actinium Pharmaceuticals
ATNM
$24.2M
$12K ﹤0.01%
+1,160
New +$8.79K
EPHE icon
3920
iShares MSCI Philippines ETF
EPHE
$147M
$12K ﹤0.01%
458
-183
-29% -$4.63K
EYPT icon
3921
EyePoint Inc
EYPT
$1.13B
$12K ﹤0.01%
1,589
+1,007
+173% +$8.66K
FBRX icon
3922
Forte Biosciences
FBRX
$1.57B
$12K ﹤0.01%
34
FSV icon
3923
FirstService
FSV
$6.27B
$12K ﹤0.01%
123
-2,874
-96% -$255K
FTEK icon
3924
Fuel Tech
FTEK
$43.1M
$12K ﹤0.01%
+14,508
New +$10K
GPRK icon
3925
GeoPark
GPRK
$627M
$12K ﹤0.01%
1,205
-383
-24% -$3.44K

Similar funds

Tower Research Capital (TRC)'s Q2 2020 Portfolio in Review

As of Q2 2020, Tower Research Capital (TRC) held 5,222 positions worth $2.44B, up 48% from $1.64B the previous quarter. Its ten largest holdings account for 14% of the portfolio.

Tower Research Capital (TRC) deployed $442M of net new capital in Q2 2020, opening 2,059 new positions and adding to 1,821 existing holdings. Its largest new stake was Apple: 428,252 shares worth $39.1M.

By sector, the portfolio is most concentrated in Technology at 12% of assets, up from 3.1% a quarter earlier, followed by Healthcare and Financials.

On the sell side, the largest reduction was State Street SPDR S&P 500 ETF Trust, an estimated $342M trimmed.

  • Tower Research Capital (TRC)'s largest Q2 2020 buy was Apple: 428,252 shares worth $39.1M.
  • Tower Research Capital (TRC) added most to iPath Series B S&P 500 VIX Short-Term Futures ETN in Q2 2020, an estimated $55.3M increase.
  • Tower Research Capital (TRC)'s biggest Q2 2020 reduction was State Street SPDR S&P 500 ETF Trust, cutting an estimated $342M.
  • Tower Research Capital (TRC) fully exited First Trust Technology AlphaDEX Fund in Q2 2020, selling an estimated $2.52M.
  • Tower Research Capital (TRC)'s ten largest holdings make up 14% of its $2.44B portfolio in Q2 2020.
  • Tower Research Capital (TRC) opened 2,059 new positions and closed 374 in Q2 2020.
  • Tower Research Capital (TRC)'s portfolio value rose 48% quarter-over-quarter to $2.44B.

Based on Tower Research Capital (TRC)'s 13F filing for Q2 2020, filed 13 Aug 2020.